67630-01-7

Basic information

• Product Name: L-Phenylalanine, 4-aMino-N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester
• Synonyms: L-Phenylalanine, 4-aMino-N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester;(S)-ethyl 3-(4-aMinophenyl)-2-(tert-butoxycarbonylaMino)propanoate
• CAS NO: 67630-01-7
• Molecular Formula: C₁₆H₂₄N₂O₄
• Molecular Weight: 308.37276
• Mol File: 67630-01-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 471.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1.130±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 11.18±0.46(Predicted)
• CAS DataBase Reference: L-Phenylalanine, 4-aMino-N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, 4-aMino-N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester(67630-01-7)
• EPA Substance Registry System: L-Phenylalanine, 4-aMino-N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester(67630-01-7)

Safety Data

• Hazardous Substances Data: 67630-01-7(Hazardous Substances Data)

Usage

General Description

L-Phenylalanine, 4-amino-N-[(1,1-dimethylethoxy)carbonyl]-, ethyl ester is a chemical compound commonly used in the production of pharmaceuticals and as a building block for various chemical reactions. It is an ethyl ester derivative of L-phenylalanine, an essential amino acid that plays a vital role in protein synthesis and other metabolic processes in the body. The ethyl ester form of L-phenylalanine is often used in drug development due to its improved stability and bioavailability compared to the free amino acid form. It is also used in the synthesis of peptides and as a reagent in organic chemistry reactions. Overall, L-Phenylalanine, 4-amino-N-[(1,1-dimethylethoxy)carbonyl]-, ethyl ester is an important chemical compound with a wide range of applications in the pharmaceutical and chemical industries.

Upstream product

• 67630-00-6 N-(tert-butyloxycarbonyl)-4-nitro-L-phenylalanine ethyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 58816-66-3 (S)-2-amino-3-(4-nitrophenyl)propionic acid ethyl ester hydrochloride 
• 33305-77-0 Boc-Phe(p-NO₂)-OH 

Downstream Products

• 85676-47-7 Boc-Gph-OEt 
• 189744-27-2 N-boc-L-3-(4-bis(hydroxyethyl)aminophenyl)alanine ethyl ester 
• 263276-03-5 N-Boc-4-[(3',5'-dichloroisonicotinoyl)amino]-(L)-phenylalanine ethyl ester 
• 369648-61-3 ethyl-(2S)-2-amino-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoate 
• 369648-62-4 ethyl-(2S)-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]-2-[(t-butoxycarbonyl)amino]propanoate 
• 204856-74-6 N-t-butoxycarbonyl-DL-4-(methylsulfonylamino)phenylalanine 
• 220388-32-9 N-t-butoxycarbonyl-DL-4-(phenylsulfonylamino)phenylalanine 
• 1031337-78-6 ethyl N-(tert-butoxycarbonyl)-4-[(3-nitropyridin-2-yl)amino]-L-phenylalaninate 
• 1031339-11-3 ethyl N-(tert-butoxycarbonyl)-4-[(3,5-dinitropyridin-2-yl)amino]-L-phenylalaninate 
• 916834-70-3 Boc-aminoPhe-OEt_.CNCA 
• 148-82-3 L-PAM 
• 3223-07-2 L-4-[bis(2-chloroethyl)amino]phenylalanine hydrochloride 

Relevant articles and documents

Synthesis method of melphalan

The invention discloses a synthesis method of melphalan. The synthesis method comprises the following steps: (a), carrying out a reduction reaction: taking a compound which has a structure shown as aformula I as a raw material, and carrying out reduction reaction on the compound, a catalyst and hydrogen to obtain a reduction product shown in formula I, wherein in the formula I, X represents one of oxygen or nitrogen; R1 represents one of hydrogen, saturated alkyl group or unsaturated alkyl group; R2 and R3 respectively represent one of the hydrogen, alkyl carbonyl, amino carbonyl or alkoxycarbonyl; carrying out alkylation reaction on an alkylating reagent and the obtained reduction product in the presence of an acid binding agent to obtain an alkylated product; carrying out hydrolysis reaction on the alkylated product in acid or alkali; after concentrating, adjusting a pH value, extracting, washing and carrying out salification in dried alcohol or ester solvents of hydrochloric acid;then refining with acetonitrile to obtain melphalan hydrochloride. The synthesis method of the melphalan, disclosed by the invention, has the advantages of high yield in each step, simple operation, mild reaction conditions, no high-toxic or high-corrosion reagent, high purity of the obtained product and suitability for industrialized production.

Fluorescent amino acid derivatives

The subject of the present invention is to provide a fluorescent substance excitable under visible light, having higher photostability and a long fluorescence lifetime. Another subject is to provide a fluorescent substance consists of a non-natural amino

VLA-4 ANTAGONISTS

Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn’s disease, multiple sclerosis, asthma, and rheumatoid arthritis.